OrthoIQ, Inc. — SEC Form D Filing

OrthoIQ, Inc. filed an SEC Form D on October 23, 2026, reporting $1.08M raised in Biotechnology.

Form D filing details

Filing
SEC Form D
Filing date
October 23, 2026
Amount reported
$1.08M
Round stage
Seed stage, as evidenced by a $1.08 million convertible debt raise intended to fund early product development and clinical validation.
Industry
Biotechnology
Website
https://orthoiq.com

What the company does

Securities: Convertible Debt. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Orthopedic surgeons lack real-time objective data during operations, leading to inconsistent implant fixation and higher rates of surgical complications.

Solution

OrthoIQ builds intelligent surgical instrumentation integrated with sensors and predictive analytics to provide real-time intraoperative feedback.

Why now

Recent miniaturization of low-power sensors and edge computing enables real-time surgical data collection without adding friction to operating room workflows.

Source: SEC EDGAR Form D filing